FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155532009> ?p ?o ?g. }

• W2155532009 endingPage "11" @default.
• W2155532009 startingPage "2" @default.
• W2155532009 abstract "Currently, tumour response following drug treatment is based on measurement of anatomical size changes. This is often done according to Response Evaluation Criteria in Solid Tumours (RECIST) and is generally performed every 2-3 cycles. Bone metastases, being the most common site of distant metastases in breast cancer, are not measurable by RECIST. The standard response measurement provides no insight in changes of molecular characteristics. In the era of targeted medicine, knowledge of specific molecular tumour characteristics becomes more important. A potential way to assess this is by means of molecular imaging. Molecular imaging can visualise general tumour processes, such as glucose metabolism with (18)F-fluorodeoxyglucose ((18)F-FDG) and DNA synthesis with (18)F-fluorodeoxythymidine ((18)F-FLT). In addition, an increasing number of more specific targets, such as hormone receptors, growth factor receptors, and growth factors can be visualised. In the future molecular imaging may thus be of value for personalised treatment-selection by providing insight in the expression of these drug targets. Additionally, when molecular changes can be detected early during therapy, this may serve as early predictor of response. However, in order to define clinical utility of this approach results from (ongoing) clinical trials is required. In this review we summarise the potential role of molecular imaging of general tumour processes as well as hormone receptors, growth factor receptors, and tumour micro-environment for predicting and monitoring treatment response in breast cancer patients." @default.
• W2155532009 created "2016-06-24" @default.
• W2155532009 creator A5011165801 @default.
• W2155532009 creator A5013384569 @default.
• W2155532009 creator A5025446346 @default.
• W2155532009 creator A5026737553 @default.
• W2155532009 creator A5049977439 @default.
• W2155532009 creator A5061495577 @default.
• W2155532009 creator A5063867827 @default.
• W2155532009 creator A5072881153 @default.
• W2155532009 date "2013-10-01" @default.
• W2155532009 modified "2023-09-25" @default.
• W2155532009 title "Molecular imaging for monitoring treatment response in breast cancer patients" @default.
• W2155532009 cites W1809083310 @default.
• W2155532009 cites W1906753921 @default.
• W2155532009 cites W1963755646 @default.
• W2155532009 cites W1967438857 @default.
• W2155532009 cites W1976594736 @default.
• W2155532009 cites W2011240752 @default.
• W2155532009 cites W2012534378 @default.
• W2155532009 cites W2013147142 @default.
• W2155532009 cites W2013373169 @default.
• W2155532009 cites W2015042013 @default.
• W2155532009 cites W2019607817 @default.
• W2155532009 cites W2021777913 @default.
• W2155532009 cites W2023915585 @default.
• W2155532009 cites W2026156566 @default.
• W2155532009 cites W2027993536 @default.
• W2155532009 cites W2030296201 @default.
• W2155532009 cites W2034433890 @default.
• W2155532009 cites W2036095734 @default.
• W2155532009 cites W2036391644 @default.
• W2155532009 cites W2043824692 @default.
• W2155532009 cites W2053489770 @default.
• W2155532009 cites W2056556973 @default.
• W2155532009 cites W2056579307 @default.
• W2155532009 cites W2057389078 @default.
• W2155532009 cites W2060008081 @default.
• W2155532009 cites W2076424556 @default.
• W2155532009 cites W2077129920 @default.
• W2155532009 cites W2080937445 @default.
• W2155532009 cites W2082717401 @default.
• W2155532009 cites W2085562053 @default.
• W2155532009 cites W2086353780 @default.
• W2155532009 cites W2087382494 @default.
• W2155532009 cites W2091164695 @default.
• W2155532009 cites W2095156669 @default.
• W2155532009 cites W2095627442 @default.
• W2155532009 cites W2095704084 @default.
• W2155532009 cites W2098775844 @default.
• W2155532009 cites W2100265880 @default.
• W2155532009 cites W2103754146 @default.
• W2155532009 cites W2105398998 @default.
• W2155532009 cites W2107271788 @default.
• W2155532009 cites W2108549165 @default.
• W2155532009 cites W2112963210 @default.
• W2155532009 cites W2116818526 @default.
• W2155532009 cites W2116955161 @default.
• W2155532009 cites W2117692326 @default.
• W2155532009 cites W2118728607 @default.
• W2155532009 cites W2119065193 @default.
• W2155532009 cites W2119642155 @default.
• W2155532009 cites W2119689571 @default.
• W2155532009 cites W2120798040 @default.
• W2155532009 cites W2122574381 @default.
• W2155532009 cites W2122767481 @default.
• W2155532009 cites W2127990627 @default.
• W2155532009 cites W2130870133 @default.
• W2155532009 cites W2137329784 @default.
• W2155532009 cites W2137478903 @default.
• W2155532009 cites W2141393790 @default.
• W2155532009 cites W2146942747 @default.
• W2155532009 cites W2149366624 @default.
• W2155532009 cites W2150792456 @default.
• W2155532009 cites W2153283011 @default.
• W2155532009 cites W2155263737 @default.
• W2155532009 cites W2156004996 @default.
• W2155532009 cites W2156677665 @default.
• W2155532009 cites W2158038535 @default.
• W2155532009 cites W2159441246 @default.
• W2155532009 cites W2159967578 @default.
• W2155532009 cites W2160499123 @default.
• W2155532009 cites W2162519832 @default.
• W2155532009 cites W2164394286 @default.
• W2155532009 cites W2165782799 @default.
• W2155532009 cites W2169149961 @default.
• W2155532009 cites W2170273915 @default.
• W2155532009 cites W2170453842 @default.
• W2155532009 cites W2185510999 @default.
• W2155532009 cites W4233287607 @default.
• W2155532009 cites W4239989216 @default.
• W2155532009 doi "https://doi.org/10.1016/j.ejphar.2013.01.079" @default.
• W2155532009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23545359" @default.
• W2155532009 hasPublicationYear "2013" @default.
• W2155532009 type Work @default.
• W2155532009 sameAs 2155532009 @default.
• W2155532009 citedByCount "13" @default.
• W2155532009 countsByYear W21555320092014 @default.

• next